PURPOSE: The Wills Eye Glaucoma Research Center initiated a 2-year demonstration project to develop and implement a community-based intervention to improve detection and management of glaucoma in Philadelphia. METHODS: The glaucoma detection examination consisted of: ocular, medical, and family history; visual acuity testing; corneal pachymetry; biomicroscopy of the anterior segment; intraocular pressure (IOP) measurement; gonioscopy; funduscopy; automated visual field testing; and fundus-color photography. Treatment included laser surgery and/or IOP-lowering medication. A cost analysis was conducted to understand resource requirements. Outcome measures included; prevalence of glaucoma-related pathology and other eye diseases among high-risk populations; the impact of educational workshops on level of knowledge about glaucoma (assessed by pre- and post-test evaluation); and patient satisfaction of the glaucoma detection examinations in the community (assessed by satisfaction survey). Treatment outcome measures were change in IOP at 4-6 weeks and 4-6 months following selective laser trabeculoplasty treatment, deepening of the anterior chamber angle following laser-peripheral iridotomy treatment, and rate of adherence to recommended follow-up examinations. Cost outcomes included total program costs, cost per case of glaucoma detected, and cost per case of ocular disease detected. RESULTS: This project enrolled 1649 participants (African Americans aged 50+ years, adults 60+ years and individuals with a family history of glaucoma). A total of 1074 individuals attended a glaucoma educational workshop and 1508 scheduled glaucoma detection examination appointments in the community setting. CONCLUSIONS: The Philadelphia Glaucoma Detection and Treatment Project aimed to improve access and use of eye care and to provide a model for a targeted community-based glaucoma program.
PURPOSE: The Wills Eye Glaucoma Research Center initiated a 2-year demonstration project to develop and implement a community-based intervention to improve detection and management of glaucoma in Philadelphia. METHODS: The glaucoma detection examination consisted of: ocular, medical, and family history; visual acuity testing; corneal pachymetry; biomicroscopy of the anterior segment; intraocular pressure (IOP) measurement; gonioscopy; funduscopy; automated visual field testing; and fundus-color photography. Treatment included laser surgery and/or IOP-lowering medication. A cost analysis was conducted to understand resource requirements. Outcome measures included; prevalence of glaucoma-related pathology and other eye diseases among high-risk populations; the impact of educational workshops on level of knowledge about glaucoma (assessed by pre- and post-test evaluation); and patient satisfaction of the glaucoma detection examinations in the community (assessed by satisfaction survey). Treatment outcome measures were change in IOP at 4-6 weeks and 4-6 months following selective laser trabeculoplasty treatment, deepening of the anterior chamber angle following laser-peripheral iridotomy treatment, and rate of adherence to recommended follow-up examinations. Cost outcomes included total program costs, cost per case of glaucoma detected, and cost per case of ocular disease detected. RESULTS: This project enrolled 1649 participants (African Americans aged 50+ years, adults 60+ years and individuals with a family history of glaucoma). A total of 1074 individuals attended a glaucoma educational workshop and 1508 scheduled glaucoma detection examination appointments in the community setting. CONCLUSIONS: The Philadelphia Glaucoma Detection and Treatment Project aimed to improve access and use of eye care and to provide a model for a targeted community-based glaucoma program.
Entities:
Keywords:
Access to eye care; community-based; glaucoma detection; glaucoma treatment; underserved population
Authors: A van Gestel; C A B Webers; H J M Beckers; M C J M van Dongen; J L Severens; F Hendrikse; J S A G Schouten Journal: Eye (Lond) Date: 2010-11-05 Impact factor: 3.775
Authors: Joshua D Stein; Denise S Kim; Leslie M Niziol; Nidhi Talwar; Bin Nan; David C Musch; Julia E Richards Journal: Ophthalmology Date: 2011-02-18 Impact factor: 12.079
Authors: Fotis Topouzis; Anne L Coleman; Alon Harris; Archimidis Koskosas; Panayiota Founti; Gordon Gong; Fei Yu; Eleftherios Anastasopoulos; Theofanis Pappas; M Roy Wilson Journal: Am J Ophthalmol Date: 2007-11-28 Impact factor: 5.258
Authors: Brent Siesky; Alon Harris; Aditya Belamkar; Ryan Zukerman; Avery Horn; Alice Verticchio Vercellin; Kristen A Mendoza; Paul A Sidoti; Francesco Oddone Journal: J Glaucoma Date: 2022-03-29 Impact factor: 2.290
Authors: Ahmed A Almazroa; Maria A Woodward; Paula Anne Newman-Casey; Manjool M Shah; Angela R Elam; Shivani S Kamat; Carrie A Karvonen-Gutierrez; Sarah D Wood; Navasuja Kumar; Sayoko E Moroi Journal: Clin Ophthalmol Date: 2020-11-16
Authors: Cindy X Zheng; Wanda D Hu; Judie Tran; Linda Siam; Giuliana G Berardi; Harjeet Sembhi; Lisa A Hark; L Jay Katz; Michael Waisbourd Journal: J Community Health Date: 2016-04
Authors: Michael Waisbourd; Noelle L Pruzan; Deiana Johnson; Angela Ugorets; John E Crews; Jinan B Saaddine; Jeffery D Henderer; Lisa A Hark; L Jay Katz Journal: Ophthalmology Date: 2016-05-22 Impact factor: 12.079
Authors: Benjamin E Leiby; Sarah E Hegarty; Tingting Zhan; Jonathan S Myers; L Jay Katz; Julia A Haller; Michael Waisbourd; Christine Burns; Meskerem Divers; Jeanne Molineaux; Jeffrey Henderer; Charles Brodowski; Lisa A Hark Journal: Prev Chronic Dis Date: 2021-05-20 Impact factor: 2.830
Authors: Dena Ballouz; Juno Cho; Maria A Woodward; Angela R Elam; David C Musch; Jason Zhang; Sayoko E Moroi; Leroy Johnson; Jean Cederna; Paula A Newman-Casey Journal: J Glaucoma Date: 2021-05-01 Impact factor: 2.290
Authors: Lisa A Hark; Deiana M Johnson; Giuliana Berardi; Neal S Patel; Lichuan Zeng; Yang Dai; Eileen L Mayro; Michael Waisbourd; L Jay Katz Journal: Patient Prefer Adherence Date: 2016-09-08 Impact factor: 2.711